Certified by Founder Lodge
Crossbow Therapeutics, Inc
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $80,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodie
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 12 ,2023 | Series A | $80,000,000 |
Eli Lilly and Company
Polaris Partners
Pfizer
MPM BioImpact
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
